Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
ADAM Sheddase Activity Promotes the Detachment of Small Extracellular Vesicles From the Plasma Membrane
Chloé Bizingre1,2, Zaira Arellano-Anaya1,2, Flavien Picard3
1INSERM UMR-S 1124, Paris, France.
Abstract:
Small extracellular vesicles (SEVs) are involved in diverse functions in normal and pathological situations, including intercellular communication, immunity, metastasis and neurodegeneration. Cell release of SEVs is assumed to occur passively right after multivesicular bodies of the endocytic pathway fuse with the plasma membrane. We show here that the completion of SEV release depends on membrane-bound ADAM10 and ADAM17 sheddases that promote the detachment of SEVs from the cell surface by catalysing the cleavage of adhesion proteins of the SEV membrane. The intensity of ADAM10/17-mediated release of SEVs depends on a balanced control of 3-phosphoinositide-dependent kinase 1 (PDK1) and ERK1/2 signalling pathways converging on 90-kDa ribosomal S6 kinase-2 (RSK2), which, in turn, fine-tunes ADAM17 bioavailability and ADAM10/17 enzymatic activities at the plasma membrane, according to a mechanism that relies, at least in part, on variation of the rhomboid-like pseudoprotease iRhom2 cell surface level. By identifying a new proteolytic step involved in the basal release of SEVs, our work may help understand how the deregulation of ADAM10/17-mediated discharge of SEVs contributes to several pathological states.
Insights
Small extracellular vesicles (SEVs) release is actively regulated by ADAM10/17 sheddases, which cleave adhesion proteins. This process is controlled by PDK1 and ERK1/2 signaling pathways, impacting SEV release in health and disease.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Small extracellular vesicles (SEVs) mediate intercellular communication in various physiological and pathological processes.
- SEV release has been traditionally considered a passive event following the fusion of endocytic multivesicular bodies with the plasma membrane.
Purpose of the Study:
- To investigate the molecular mechanisms regulating the release of small extracellular vesicles (SEVs).
- To identify the role of specific proteases and signaling pathways in SEV detachment from the cell surface.
Main Methods:
- Investigated the role of ADAM10 and ADAM17 sheddases in SEV release.
- Analyzed the involvement of 3-phosphoinositide-dependent kinase 1 (PDK1), ERK1/2, and 90-kDa ribosomal S6 kinase-2 (RSK2) signaling pathways.
- Examined the influence of iRhom2 on ADAM10/17 activity and SEV release.
Main Results:
- ADAM10 and ADAM17 sheddases are crucial for the final detachment of SEVs from the cell surface by cleaving adhesion proteins.
- SEV release intensity is modulated by the interplay between PDK1 and ERK1/2 signaling, converging on RSK2.
- RSK2 regulates ADAM17 bioavailability and ADAM10/17 enzymatic activity, partly via iRhom2 levels.
Conclusions:
- SEV release is an actively regulated proteolytic process, not merely passive.
- Understanding ADAM10/17-mediated SEV discharge offers insights into pathological conditions involving SEV deregulation.
More Related Videos
Related Concept Videos
Pinching-off of Coated Vesicles
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Clathrin Coated Vesicles
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Intracellular Signaling Affects Focal Adhesions
Some...

